Literature DB >> 20340020

Outcome of Boyd-McLeod procedure for recalcitrant lateral epicondylitis of elbow.

V R M Reddy1, K S Satheesan, N Bayliss.   

Abstract

Various surgical procedures including percutaneous and open release and arthroscopic procedures have been described to treat recalcitrant tennis elbow. We present the outcome of Boyd-McLeod surgical procedure for tennis elbow resistant to non-operative treatment in twenty-seven patients (twenty-nine limbs). Boyd McLeod procedure involves excision of the proximal portion of the annular ligament, release of the origin of the extensor muscles, excision of the bursa if present, and excision of the synovial fringe. The average time interval from the onset of symptoms of tennis elbow until surgery was 28 months (range 8-72 months). Of those patients, 91% reported complete relief of symptoms with return to full normal activities including sports. Average post-operative time for return to professional/recreational activity was 5 weeks. One case developed pain secondary to ectopic bone formation after surgery, which settled after excision, and in another there was no pain relief with Boyd McLeod procedure. Two patients had scar tenderness that did not affect the final outcome. We conclude that Boyd-McLeod procedure is an effective treatment option in patients with resistant lateral epicondylitis.

Entities:  

Mesh:

Year:  2010        PMID: 20340020     DOI: 10.1007/s00296-010-1450-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  Day-case simple extensor origin release for tennis elbow.

Authors:  M J Bankes; J H Jessop
Journal:  Arch Orthop Trauma Surg       Date:  1998       Impact factor: 3.067

2.  Tennis elbow.

Authors:  H B Boyd; A C McLeod
Journal:  J Bone Joint Surg Am       Date:  1973-09       Impact factor: 5.284

3.  Tennis elbow: its course, natural history, conservative and surgical management.

Authors:  R W Coonrad; W R Hooper
Journal:  J Bone Joint Surg Am       Date:  1973-09       Impact factor: 5.284

4.  V-Y slide of the common extensor origin for lateral elbow tendonopathy.

Authors:  G M Rayan; S A Coray
Journal:  J Hand Surg Am       Date:  2001-11       Impact factor: 2.230

5.  Resistant tennis elbow.

Authors:  G H Heyse-Moore
Journal:  J Hand Surg Br       Date:  1984-02

6.  Simple lateral release in treatment of tennis elbow.

Authors:  P T Calvert; R L Allum; I S Macpherson; G Bentley
Journal:  J R Soc Med       Date:  1985-11       Impact factor: 5.344

7.  Anatomic factors related to the cause of tennis elbow.

Authors:  Robert E Bunata; David S Brown; Roderick Capelo
Journal:  J Bone Joint Surg Am       Date:  2007-09       Impact factor: 5.284

8.  Lateral extensor release for tennis elbow. A prospective long-term follow-up study.

Authors:  J Verhaar; G Walenkamp; A Kester; H van Mameren; T van der Linden
Journal:  J Bone Joint Surg Am       Date:  1993-07       Impact factor: 5.284

9.  Patient satisfaction after open release of common extensor origin in treating resistant tennis elbow.

Authors:  Suresh Thomas; Guy Broome
Journal:  Acta Orthop Belg       Date:  2007-08       Impact factor: 0.500

10.  Percutaneous extensor tenotomy for chronic tennis elbow: an office procedure.

Authors:  B Yerger; T Turner
Journal:  Orthopedics       Date:  1985-10       Impact factor: 1.390

View more
  3 in total

1.  The Boyd-McLeod procedure for tennis elbow: mid- to long-term results.

Authors:  Richard Jeavons; Andrew J Berg; Ian Richards; Neil Bayliss
Journal:  Shoulder Elbow       Date:  2014-07-04

Review 2.  Clinical Outcomes of Open versus Arthroscopic Surgery for Lateral Epicondylitis, Evidence from a Systematic Review.

Authors:  Ali Moradi; Pouria Pasdar; Hassan Mehrad-Majd; Mohammad H Ebrahimzadeh
Journal:  Arch Bone Jt Surg       Date:  2019-03

Review 3.  Lateral Epicondylitis-Narrative Review on Surgical Options for Recalcitrant Cases.

Authors:  Jonathan Herald; Munis Ashraf; M Shyam Sundar; David V Rajan
Journal:  Indian J Orthop       Date:  2021-02-09       Impact factor: 1.251

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.